Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:1.6.5.4 (SOR)
 720 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The convergence zone method is currently used routinely to quantify valvular regurgitation, particularly mitral insufficiency, but also aortic and tricuspid regurgitation. It is quick to perform, requires relatively little training and remains valid in the presence of atrial fibrillation and in the association of regurgitation-stenosis. It relies on the measurement of output at the level of an isovelocity hemisphere and allows calculation of the regurgitant orifice surface (SOR) and the regurgitant volume per beat (VR). It is reserved for severe regurgitation corresponding to angiographic grade 4: SOR > 40 mm2 and VR > 60 ml for mitral insufficiency, SOR > 30 mm2 and VR > 60 ml for aortic insufficiency, and SOR > 40 mm2 and VR > 40 ml for tricuspid insufficiency.
Arch Mal Coeur Vaiss 2003 Jun
PMID:[Quantification of valvular regurgitation by the convergence zone method]. 1287 Jan 90

Techniques of insertion of implantable venous devices have been widely described. The use of ultrasound guidance is part of the good practice recommendations of the SOR 2008 but there are few data in the literature and recommendations are based only on expert agreement. To this end we conducted a prospective, single-center study from January 2008 to August 2009 on percutaneous ultrasound-guided insertion of implantable devices. In addition to age, sex, the therapeutic indication and the site of implantation, we identified the operative time and number of venipunctures performed for each procedure. We then identified the infectious complications at three months and thromboembolic complications at 1 year and a half. Our study examined 102 consecutive patients. The mean age was 61.8 years (28-90); 71% of patients were men. For 101 patients, the internal jugular vein was punctured, the subclavian vein in one patient. In 86% of cases, the implantable venous device was inserted into the right vein. The average length of procedure was 30 minutes (18-60) for a single-vein puncture. Among the 102 patients, the overall morbidity was 7.8% with four infections (3.9%) and four thromboses (3.9%). There were no immediate perioperative complications (arterial puncture, hematoma, pneumothorax). In conclusion, percutaneous ultrasound-guided insertion of implantable venous devices in the internal jugular vein is a safe, minimally invasive technique which complies with the 2008 SOR recommendations by preventing the risk of venous thrombosis and avoiding repeated venous puncture. Less invasive than the open surgical approach, ultrasound-guided insertion is safer than puncture based solely on anatomical landmarks. In summary, this is a reliable, simple and easily reproducible technique which limits iatrogenic risks and improves patient comfort.
J Mal Vasc 2013 Feb
PMID:[Ultrasound-guided percutaneous insertion of implantable venous devices: a review of 102 patients]. 2335 27